Want to track ANIK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Anika Therapeutics Inc. (ANIK) Statistics
Valuation metrics
Market Cap 206.5M
Enterprise value 187.63M
Trailing P/E (ttm) -19.32
Forward P/E -
PEG ratio -0.17
Price/Sales (ttm) 1.75
Price/Book (mrq) 1.54
Enterprise Value/Revenue 1.61
Enterprise Value/EBITDA -40.49
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 39.3K
Average volume (90 days) 100.11K
Price summary
52-Week low 7.87
52-Week high 16.49
Beta -
50-Day moving average 14.7
200-Day moving average 12.93
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.1%
Operating margin -0.11%
Operational effectiveness
Return on assets -0.06%
Return on equity -0.08%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 8.59
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.82
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.03
Total debt (mrq) -
Total Debt/Equity (mrq) 0.19
Current ratio (mrq) 4.46%
Book value per share (mrq) 9.9
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
